NORTH CHICAGO, Ill. — Abbott Laboratories (ABT) on Wednesday reported a third-quarter loss of $329 million, after reporting a profit in the same period a year earlier.

The North Chicago, Illinois-based company said it had a loss of 22 cents per share. Earnings, adjusted for one-time gains and costs, came to 59 cents per share.

The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share.

The maker of infant formula, medical devices and drugs posted revenue of $5.3 billion in the period, which did not meet Street forecasts. Eight analysts surveyed by Zacks expected $5.31 billion.

Abbott expects full-year earnings in the range of $2.19 to $2.21 per share.

Abbott shares have fallen slightly more than 8 percent since the beginning of the year, while the Standard & Poor’s 500 index has climbed almost 5 percent. The stock has declined slightly more than 2 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ABT at


Keywords: Abbott, Earnings Report

VIAThe Associated Press
The AP is one of the largest and most trusted sources of independent newsgathering. AP is neither privately owned nor government-funded; instead, as a not-for-profit news cooperative owned by its American newspaper and broadcast members, it can maintain its single-minded focus on newsgathering and its commitment to the highest standards of objective, accurate journalism.